Alnylam Pharmaceuticals ALNY
NASDAQ ALNY
$255.36 -0.60 (-0.23%)
At close: Sep 28, 2026 · 4:00 PM EDT

Alnylam Pharmaceuticals (ALNY) Receivables - Other (2020 - 2021)

Updated

Alnylam Pharmaceuticals (ALNY) recorded Receivables - Other of $500 million in Q2 2021, unchanged from the prior quarter.

Analysis

Alnylam Pharmaceuticals (ALNY) Receivables - Other (2020 - 2021) Analysis & Trends

Starting with Q3 2020, Alnylam Pharmaceuticals' Receivables - Other history includes 4 quarters.

  • Per Business Quant, the preceding three quarters came in at $500 million (Q1 2021), $500 million (Q4 2020) and $500 million (Q3 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 653.54 Bn 572.07 Bn 17.26 Bn
2 AbbVie 467.01 Bn 440.17 Bn 12.70 Bn
3 Merck 367.16 Bn 321.59 Bn 12.21 Bn
4 Novartis Ag 277.56 Bn 233.43 Bn 11.24 Bn
5 Astrazeneca 258.23 Bn 231.79 Bn 12.86 Bn
6 Amgen 224.14 Bn 179.54 Bn 7.24 Bn
7 Gilead Sciences 187.30 Bn 161.42 Bn 6.22 Bn
8 Pfizer 163.47 Bn 110.41 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.31 Bn 105.31 Bn 2.84 Bn
10 Alnylam Pharmaceuticals 34.23 Bn 22.28 Bn 992.69 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 500.00 Mn
Mar 31, 2021 500.00 Mn
Dec 31, 2020 500.00 Mn
Sep 30, 2020 500.00 Mn
API Access

Alnylam Pharmaceuticals Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=ALNY&period=max&api_key=YOUR_API_KEY